Press Releases for Switzerland
European Commission Approves Seagen’s TUKYSA® (tucatinib) for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
– Approved for Adult Patients with HER2-Positive Metastatic Breast Cancer Who Have Received at Least Two Prior Anti-HER2 Treatment Regimens – – First HER-2 Tyrosine Kinase Inhibitor Combination Regimen to […]
AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
07/01/2021 — NORTH AUGUSTA, S.C. — (BUSINESS WIRE) AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly […]
Alpian Selects Temenos SaaS to Launch Pioneering New Digital Bank and Take Swiss Private Banking Experience to the Mass Affluent
Alpian will offer digital private banking and wealth management services, combined with human expertise, to tap into CHF 660bn private banking opportunity With Temenos SaaS, the new Swiss digital bank […]
Siemens Smart Infrastructure Chooses AWS as Its Preferred Cloud Provider for SAP Environments
Siemens Smart Infrastructure becomes first company within Siemens AG to move production-scale, business-critical SAP environments to the cloud 03/12/2020 — SEATTLE — (BUSINESS WIRE) Today, Amazon Web Services (AWS), an […]
Global Coalition Unites to Tackle the Urban Water Crisis and Address Climate Change Through Public-Private Collaboration
Companies, policymakers, cities and citizens will develop and scale innovations that reinvent water consumption in the home and drive system-level transformation 27/10/2020 — GENEVA — (BUSINESS WIRE) Launched today, the […]
Ormendes SA – First Published Clinical Trial In COVID-19 Suggests Role of Live Biotherapeutic Candidate in Seriously Ill Patients
Italian clinical study finds combined strains of live bacteria reduced diarrhea and prevented progression of symptoms in hospitalized COVID19-patients 11/09/2020 — LAUSANNE, Switzerland — (BUSINESS WIRE) Ormendes SA is proud […]
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19
With resurgent COVID-19, enrollment has accelerated in Miami, Houston, and Irvine Data Monitoring Committee determined that so far RLF-100 has generated no drug-related Serious Adverse Events or other safety concerns […]
NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Aviptadil) for the Treatment of Respiratory Distress in COVID-19
Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19 underscores the urgent need for new treatment options for these patients. At […]
Christie’s Global Auction Channel Sales Total £3.9 Billion/US$5.0 Billion In 2019
20/12/2019 — LONDON — (BUSINESS WIRE) Christie’s announced auction channel sales of £3.9 billion (US$5 billion) for 2019. Key highlights for the year included: A new top price for any […]
Personalis, Inc. to Present at ESMO Immuno-Oncology Congress 2019
11/12/2019 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will participate in the ESMO Immuno-Oncology […]